MedDataX Logo

Factors Associated With Continuation of Exclusive Breastfeeding Until the Post-natal Visit

NCT ID: NCT05650684

Last Updated: 2022-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Breastfeeding promotes the health of mother and her child, and remains the reference in terms of infant nutrition. World Health Organization recommends exclusive breastfeeding for the first six months. This recommended duration is not respected in France with a median duration of breastfeeding in France at 3 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim is to study factors associated with continuation of exclusive breastfeeding until the post-natal visit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breastfeeding

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

exclusive breastfeeding postnatal visit factors associated

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

"exclusive breastfeeding" group

Women initiating exclusive breastfeeding after birth

data collection

Intervention Type OTHER

continuation of exclusive breastfeeding until the post-natal visit (6 to 8 weeks after birth)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

data collection

continuation of exclusive breastfeeding until the post-natal visit (6 to 8 weeks after birth)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* primiparous and multiparous women
* women who have initiate breastfeeding
* women aged 18 and more
* agreeing to participate in the study

Exclusion Criteria

* women whose newborn has been in intensive care unit
* women with a multiple pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université de Reims Champagne-Ardenne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

CURRS CURRS

Role: CONTACT

Phone: 0326918822

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022_RIPH_013_Poursuit-Allait

Identifier Type: -

Identifier Source: org_study_id